Download PDF
Thromb Haemost 1992; 68(02): 099-101
DOI: 10.1055/s-0038-1656330
Original Article
Schattauer GmbH Stuttgart

Contributions of Mayme Williams to the Elucidation of the Multiple Functions of Plasma Kininogens

Robert W Colman
The Thrombosis Research Center, Temple University School of Medicine, Philadelphia, PA, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
03 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Jacobsen S, Kriz M. Some data on two purified kininogens from human plasma. Br J Pharmacol 1967; 29: 25-36
    PubMedGoogle Scholar
  • 2 Meier HL, Pierce JV, Colman RW, Kaplan AP. Activation and function of human Hageman factor: The role of high molecular weight kininogen and prekallikrein. J Clin Invest 1977; 60: 18-31
    CrossrefPubMedGoogle Scholar
  • 3 Mandle RJ, Colman RW, Kaplan AP. Identification of prekallikrein and high molecular weight kininogen as a complex in human plasma. Proc Natl Acad Sci USA 1976; 73: 4179-4183
    CrossrefPubMedGoogle Scholar
  • 4 Thompson RE, Mandle Jr R, Kaplan AP. Studies of binding of prekallikrein and factor XI to high molecular weight kininogen and its light chain. Proc Natl Acad Sci USA 1979; 76: 4862-4866
    CrossrefPubMedGoogle Scholar
  • 5 Schapira M, Scott CF, Colman RW. Protection of human plasma kallikrein from inactivation by Cl-inhibitor and other protease inhibitors: The role of high molecular weight kininogen. Biochemistry 1981; 20: 2738-2743
    CrossrefPubMedGoogle Scholar
  • 6 Scott CF, Schapira M, James HL, Cohen AB, Colman RW. Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha-1-protease inhibitor and protective effect of high molecular weight kininogen. J Clin Invest 1982; 69: 844-852
    CrossrefPubMedGoogle Scholar
  • 7 Schmaier AH, Silver L, Adams AL. et al The effect of high molecular weight kininogen on surface-adsorbed fibrinogen. Thromb Res 1984; 33: 51-67
    CrossrefPubMedGoogle Scholar
  • 8 Gustafson EJ, Lukasiewicz H, Wachtfogel YT. et al High molecular weight kininogen inhibits fibrinogen binding to cytoadhesins of neutrophils and platelets. J Cell Biol 1989; 109: 377-387
    CrossrefPubMedGoogle Scholar
  • 9 Sinha D, Seaman FS, Koshy A, Knight LC, Walsh PN. Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI. J Clin Invest 1984; 73: 1550-1556
    CrossrefPubMedGoogle Scholar
  • 10 Gustafson EJ, Schmaier AH, Wachtfogel YT. et al Human neutrophils contain and bind high molecular weight kininogen. J Clin Invest 1989; 84: 28-35
    CrossrefPubMedGoogle Scholar
  • 11 Puri RN, Zhou F-X, Hu C-J, Colman RF, Colman RW. High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets. Blood 1991; 77: 500-507
    PubMedGoogle Scholar
  • 12 Meloni FJ, Schmaier AH. Low molecular weight kininogen binds to platelets to modulate thrombin-induced platelet activation. J Biol Chem 1991; 266: 6786-6794
    PubMedGoogle Scholar
  • 13 Ohkubo I, Kurachi K, Takasawa T, Shiokawa H, Sasaki M. Isolation of a human cDNA for alpha-2 thiol protease inhibitor and its identity with low molecular weight kininogen. Biochemistry 1984; 23: 5691-5697
    CrossrefPubMedGoogle Scholar
  • 14 Schmaier AH, Bradford H, Silver LD. et al High molecular weight kininogen is an inhibitor of platelet calpain. J Clin Invest 1986; 77: 1565-1573
    CrossrefPubMedGoogle Scholar
  • 15 Bradford HN, Schmaier AH, Colman RW. Kinetics of inhibition of platelet calpain II by human kininogens. Biochem J 1990; 270: 83-90
    CrossrefPubMedGoogle Scholar
  • 16 Colman RW, Bagdasarian A, Talamo RC. et al Williams Trait: Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor dependent pathways. J Clin Invest 1975; 56: 1650-1662
    CrossrefPubMedGoogle Scholar
  • 17 Scott CF, Colman RW. Function and immunochemistry of prekallikrein high molecular weight kininogen complex in plasma. J Clin Invest 1980; 65: 413-421
    CrossrefPubMedGoogle Scholar
  • 18 Schapira M, Scott CF, James A. et al High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitors. Biochemistry 1982; 21: 567-572
    CrossrefPubMedGoogle Scholar
  • 19 Kitamura N, Kitagawa H, Fukushima D, Takagaki Y, Miyata T. Structural organization of the kininogen gene and a model for its evolution. J Biol Chem 1985; 260: 8610-8617
    PubMedGoogle Scholar
  • 20 Scott CF, Silver LD, Schapira M, Colman RW. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity: Evidence that this molecule exists as a procofactor. J Clin Invest 1984; 73: 954-962
    CrossrefPubMedGoogle Scholar
  • 21 Wiggins RC. Kinin release from high molecular weight kininogen by the action of Hageman factor in the absence of kallikrein. J Biol Chem 1983; 258: 8963-8970
    PubMedGoogle Scholar
  • 22 Villanueva GB, Leung L, Bradford H, Colman RW. Conformation of high molecular weight kininogen: Effects of kallikrein and factor XIa cleavage. Biochem Biophys Res Commun 1989; 158: 72-79
    CrossrefPubMedGoogle Scholar
  • 23 Kleniewski J, Dingle SS, Donaldson VH. Comparison of properties of monoclonal and polyclonal antibodies against the light chain of human high molecular weight kininogen. J Lab Clin Med 1988; 111: 93-103
    PubMedGoogle Scholar
  • 24 Scott CF, Silver L, Purdon AD, Colman RW. Cleavage of human high molecular weight kininogen by factor XIa in vitro: effect on structure and function. J Biol Chem 1985; 260: 10856-10863
    PubMedGoogle Scholar
  • 25 Vroman L, Adams AL. Findings with the recording ellipsometer suggesting rapid exchange of plasma proteins at liquid/solid interfaces. Surface Sci 1969; 16: 438-446
    CrossrefPubMedGoogle Scholar
  • 26 Brash JL, Scott CF, ten Hove P, Wojciechowski P, Colman RW. Mechanism of transient absorption of fibrinogen from plasma to solid surfaces: Role of the contact and fibrinolytic systems. Blood 1988; 71: 932-939
    PubMedGoogle Scholar
  • 27 Lindon JN, McManama G, Kushner L, Merrill EW, Salzman EW. Does the conformation of adsorbed fibrinogen dictate platelet interactions with artificial surfaces?. Blood 1986; 68: 355-362
    PubMedGoogle Scholar
  • 28 Schmaier AH, Zuckerberg A, Silverman C, Kuchibhotla J, Tuszynski GP, Colman RW. High molecular weight kininogen: a secreted platelet protein. J Clin Invest 1983; 71: 477-489
    PubMedGoogle Scholar
  • 29 Schmaier AH, Smith PM, Purdon AD, White JG, Colman RW. High molecular weight kininogen: Localization in the unstimulated and activated platelet and activation by a platelet calpain(s). Blood 1986; 67: 119-130
    PubMedGoogle Scholar
  • 30 Gustafson EJ, Schutsky D, Knight LC, Schmaier AH. High molecular weight kininogen binds to unstimulated platelets. J Clin Invest 1986; 78: 310-318
    CrossrefPubMedGoogle Scholar
  • 31 Greengard JS, Griffin JH. Receptors for high molecular weight kininogen on stimulated washed human platelets. Biochemistry 1984; 23: 6863-6869
    CrossrefPubMedGoogle Scholar
  • 32 Schapira M, Despland E, Scott CF, Boxer LA, Colman RW. Purified human plasma kallikrein aggregates human blood neutrophils. J Clin Invest 1982; 69: 1199-202
    CrossrefPubMedGoogle Scholar
  • 33 Wachtfogel YT, Kucich U, James HL. et al Human plasma kallikrein releases neutrophil elastase during blood coagulation. J Clin Invest 1983; 72: 1672-1677
    CrossrefPubMedGoogle Scholar
  • 34 Schmaier AH, Schutsky D, Farber A, Silver LD, Bradford HN, Colman RW. Determination of the bifunctional properties of high molecular weight kininogen by studies with monoclonal antibodies directed to each of its chains. J Biol Chem 1987; 262: 1405-1411
    PubMedGoogle Scholar
  • 35 Carvalho AC, DeMarinis S, Scott CF, Silver LD, Schmaier AH, Colman RW. Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome. J Lab Clin Med 1988; 112: 270-277
    PubMedGoogle Scholar
  • 36 Schapira M, Silver LD, Scott CF. et al Prekallikrein activation and high molecular weight kininogen consumption in hereditary angioedema. N Engl J Med 1983; 308: 1050-1053
    CrossrefPubMedGoogle Scholar
  • 37 Wong PY, Williams GH, Colman RW. Studies on the renin-angiotensin system in a kininogen-deficient individual. Clin Sci 1983; 65: 121-126
    CrossrefPubMedGoogle Scholar
  • 38 Raja SN, Campbell JN, Meyer RA, Colman RW. Role of kinins in pain and hyperalgesia: Psychophysical studies in a patient with kininogen deficiency. Clin Sci 1992 (in press)
    PubMedGoogle Scholar
  • 39 Scott CF, Pixley RA, Colman RW. A new assay for high molecular weight kininogen in human plasma using a chromogenic substrate. Thromb Res 1987; 48: 685-700
    CrossrefPubMedGoogle Scholar
  • 40 Scott CF, Colman RW. Sensitive antigenic determinations of high molecular weight kininogen (HK) using covalent coupling of capture antibody. J Lab Clin Med 1992; 119: 77-86
    PubMedGoogle Scholar